Abstract
1. 1. In depressive patients (DSM-III-R) treated with amitriptyline or amitriptylin oxide, the authors evaluated cognitive functions and auditory event-related potentials (AERP) before (n = 29) and after therapy (n = 17). 2. 2. AERP were elicited by an oddball paradigm. Cognitive functions were evaluated by the Zahlen-Verbindungs-Test, the Zahlen-Symbol-Test, and the Benton-Test. 3. 3. The latency of N1 seemed to be increased significantly with therapy. This is discussed in the context of a processing negativity. 4. 4. The latency of the endogenous component P3 (P300) was found to be increased with cognitive disturbances and with age but not related to mood score. It was decreased significantly with therapy. 5. 5. The registration of P3 latency is an appropriate method to demonstrate cognitive impairment and improvement with therapy in a depressive episode.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Progress in Neuropsychopharmacology & Biological Psychiatry
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.